| 1 |
35220216 | Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells. | 2022 Mar |
1 |
| 2 |
35456022 | Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H2AX, CHK2 and p53. | 2022 Apr 14 |
1 |
| 3 |
33017201 | Could Aberrant Migration Explain Metachronous Germ Cell Tumors? | 2021 Feb |
1 |
| 4 |
32457423 | Kinesin light chain 4 as a new target for lung cancer chemoresistance via targeted inhibition of checkpoint kinases in the DNA repair network. | 2020 May 26 |
2 |
| 5 |
30690027 | Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer. | 2019 Mar 1 |
1 |
| 6 |
29316526 | Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors. | 2018 Jan 20 |
1 |
| 7 |
29761796 | Study on the Mechanism of Cell Cycle Checkpoint Kinase 2 (CHEK2) Gene Dysfunction in Chemotherapeutic Drug Resistance of Triple Negative Breast Cancer Cells. | 2018 May 15 |
5 |
| 8 |
27794029 | Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. | 2017 Jan |
1 |
| 9 |
28347251 | Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin. | 2017 Mar |
6 |
| 10 |
28454371 | Synergistic effects of a novel lipid-soluble extract from Pinellia pedatisecta Schott and cisplatin on human cervical carcinoma cell lines through the regulation of DNA damage response signaling pathway. | 2017 Apr |
1 |
| 11 |
28686074 | Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer. | 2017 Aug 3 |
2 |
| 12 |
27494891 | Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells. | 2016 Aug 30 |
1 |
| 13 |
27984128 | DNA damage response in nephrotoxic and ischemic kidney injury. | 2016 Dec 15 |
1 |
| 14 |
24362713 | Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. | 2014 Jan |
1 |
| 15 |
24415413 | Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele. | 2014 Feb |
1 |
| 16 |
24480460 | Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks. | 2014 May |
1 |
| 17 |
24657486 | Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer. | 2014 Jun |
2 |
| 18 |
24853623 | Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation. | 2014 May |
1 |
| 19 |
25006835 | Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin. | 2014 Jul 8 |
1 |
| 20 |
23940574 | Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma. | 2013 |
1 |
| 21 |
24113180 | A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. | 2013 Oct 10 |
1 |
| 22 |
21592546 | The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. | 2011 Aug |
1 |
| 23 |
22312557 | The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor. | 2011 |
5 |
| 24 |
19889954 | Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. | 2010 Feb |
1 |
| 25 |
20526748 | Switching p53-dependent growth arrest to apoptosis via the inhibition of DNA damage-activated kinases. | 2010 Sep |
1 |
| 26 |
20700484 | NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. | 2010 Aug 5 |
2 |
| 27 |
20846399 | Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression. | 2010 Sep 16 |
1 |
| 28 |
18647348 | Characterization of the role of a trimeric protein phosphatase complex in recovery from cisplatin-induced versus noncrosslinking DNA damage. | 2008 Aug |
1 |
| 29 |
18762365 | Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer. | 2008 Dec 18 |
1 |
| 30 |
16596250 | Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells. | 2006 May |
4 |
| 31 |
15694385 | Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells. | 2005 Mar 11 |
6 |